Navigation Links
World Stem Cell Report 2013 highlights expert opinion and state-of-the-art science

New Rochelle, NY, December 4, 2013Mary Ann Liebert, Inc., publishers announced the publication of the World Stem Cell Report 2013, a special supplement to the peer-reviewed journal Stem Cells and Development. Dr. Graham Parker (Wayne State University School of Medicine) and Bernard Siegel (Genetics Policy Institute) serve as Co-Editors-in-Chief of the Report, joined by Rosario Isasi (McGill University) as Managing Editor.

The World Stem Cell Report is the official publication of the 2013 World Stem Cell Summit, being held December 4-6, 2013 in San Diego, CA. The Report is available to all subscribers of Stem Cells and Development and to attendees of the World Stem Cell Summit at

Notable papers in this year's Report include: "National Institutes of Health Center for Regenerative Medicine: Putting Science into Practice" by Mahendra Rao, MD, PhD, NIH Center for Regenerative Medicine; "The Ethical and Regulatory-Compliant Training and Practice of Regenerative Surgery in the United States and Abroad" by Allan Wu, MD, FACOG, FAACS, The Morrow Institute, Regenerative Surgery; "Navigating the U.S. Food and Drug Administration's Regulatory Science Initiative: An Imperative for Stem Cell Research and Regenerative Medicine Advocates" by Alan Jakimo, JD, MBA, Sidley Austin LLP; and "Key Action Items for the Stem Cell Field Looking to 2014" by Paul Knoepfler, PhD, University of California, Davis School of Medicine.

"The World Stem Cell Report is the topical foundation for the World Stem Cell Summit program, illuminating innovative solutions aimed at accelerating the delivery of effective stem cell treatments and eventual cures," says Bernard Siegel, JD, Co-Chair of the 2013 World Stem Cell Summit and Executive Director, Genetics Policy Institute (GPI, Palm Beach, FL). "Outside the laboratory, societies must find ways remove regulatory, legal, ethical, political, and business roadblocks. The Report addresses an unmet need in the literature and is an effective tool, serving as benchmark guide for moving the field forward."

"It is my pleasure as Editor-in-Chief of Stem Cells and Development to partner with Bernard Siegel and Rosario Isasi in producing the Report in support of the 2013 World Stem Cell Summit, an interdisciplinary meeting uniting researchers, clinicians, social scientists, and society leaders in the common goal of responsible stem cell based therapeutic advancement," says Graham C. Parker, PhD, Editor-in-Chief of Stem Cells and Development, Wayne State University School of Medicine (Detroit, MI).

The Summit, presented by the Genetics Policy Institute, is the flagship meeting of the international stem cell community. The Summit aims to accelerate the discovery and development of lifesaving cures and therapies, bringing global stakeholders together to solve global challenges. It builds a foundation to advance cell therapies by establishing a supportive environment of regulation, legislation, financing, reimbursement, and patient advocacy. Attendees from more than 40 nations are expected to attend this year's meeting.


Contact: Kathryn Ruehle
Mary Ann Liebert, Inc./Genetic Engineering News

Related biology news :

1. 7th World Congress for Rett Syndrome to convene in New Orleans, La., June 22-26
2. Worlds leading coral experts to gather in Australia
3. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
4. New paper examines poison resistance in snakes around the world
5. Global Information Inc. Announces Discounted Conference Registration For Bio-IT World Asia and Biodetection Technologies 2012
6. MedNet Solutions to Demonstrate Its Innovative Suite of eClinical Solutions at the 2012 Bio-IT World Conference & Expo
7. Lizard moms may prepare their babies for a stressful world
8. Botanical institutions announce plans to create first online World Flora
9. Ethical Adaptation to Climate Change envisions the good life in a harsher world
10. Different recipes for success in the world of plants
11. Camera trap video offers rare glimpse of worlds rarest gorilla
Post Your Comments:
Related Image:
World Stem Cell Report 2013 highlights expert opinion and state-of-the-art science
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):
(Date:12/1/2015)... 1, 2015  Twist Bioscience, a company focused on synthetic ... Ph.D., has been selected as one of Foreign ... the building blocks of life . Each year, Foreign ... contributions and work have changed lives and are shaping the ... is an honor to be recognized among these incredible global ...
(Date:12/1/2015)... , Dec. 1, 2015  The Minnesota High ... of the 2015 Tekne Award in the Small and ... at the Minneapolis Convention Center, ... played a significant role in developing new technologies that ... around the world. Clostridium difficile infection ...
(Date:12/1/2015)... ... December 01, 2015 , ... Park Systems , world ... scanning ion conductance microscopy module to Park NX10 that is the only product ... SICM benefits virtually all materials characterization that require measurements in liquid such as ...
(Date:12/1/2015)... Dec. 1, 2015  Symic, a clinical-stage biotherapeutics company ... matrix (ECM), today announced that it has secured $25 ... company,s pipeline, including its lead candidates SB-030 and SB-061. ... the participation by all existing major investors, as well ... total capital raised by Symic to over $43 million ...
Breaking Biology Technology: